Arch Therapeutics Provides Update on Reimbursement Strategy
Initial A4100 code being deployed and application for specific HCPCS product code to be submitted in the second calendar quarter...
United States Dan Yrigoyen Michael Abrams Arch Therapeutics Inc Pilot Program The Centers For Medicare
Source: globenewswire.com